Cargando…
SARS‐CoV‐2‐reactive T‐cell receptors isolated from convalescent COVID‐19 patients confer potent T‐cell effector function
Both B cells and T cells are involved in an effective immune response to SARS‐CoV‐2, the disease‐causing virus of COVID‐19. While B cells—with the indispensable help of CD4(+) T cells—are essential to generate neutralizing antibodies, T cells on their own have been recognized as another major player...
Autores principales: | Brunk, Fabian, Moritz, Andreas, Nelde, Annika, Bilich, Tatjana, Casadei, Nicolas, Fraschka, Sabine A. K., Heitmann, Jonas S., Hörber, Sebastian, Peter, Andreas, Rammensee, Hans‐Georg, Singh, Harpreet, Walz, Juliane, Maurer, Dominik, Wagner, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646365/ https://www.ncbi.nlm.nih.gov/pubmed/34424997 http://dx.doi.org/10.1002/eji.202149290 |
Ejemplares similares
-
T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals
por: Bilich, Tatjana, et al.
Publicado: (2021) -
Prevalence of COVID-19-associated symptoms during acute infection in relation to SARS-CoV-2-directed humoral and cellular immune responses in a mild-diseased convalescent cohort
por: Tegeler, Christian M., et al.
Publicado: (2022) -
Antigen Targets for the Development of Immunotherapies in Leukemia
por: Bauer, Jens, et al.
Publicado: (2019) -
Successful treatment of COVID‐19 infection with convalescent plasma in B‐cell‐depleted patients may promote cellular immunity
por: Kremer, Andreas E., et al.
Publicado: (2021) -
Long-Term Follow-Up of COVID-19 Convalescents—Immune Response Associated with Reinfection Rate and Symptoms
por: Seller, Anna, et al.
Publicado: (2023)